Lastly, an in vivo mouse model silencing Tgm2 in CD11b myeloid cells in HFD mice further demonstrated that reducing TGM2 in myeloid cells results in increased pro-inflammatory responses, along with increased obesity and IR. This evidence concerns the gene ITGAM and obesity due to melanocortin 4 receptor deficiency.